Goldman Sachs BDC, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-06-30; filed 2026-08-06.
0001193125-26-338331
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2026-09-30; filed 2026-11-05.
0001193125-26-450076
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 10 previous paragraphs and 12 current paragraphs.
8 unchanged; 2 reworded; 2 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
An investment in our securities involves a high degree of risk. There have been no material changes to the risk factors previously reported under Item 1A. “Risk Factors” of our annual report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC on February 26, 2026. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may materially affect our business, financial condition and/or operating results.
Added paragraphs (2)
Current report
For further details, see Note 9 “Net Assets—Common Stock Repurchase Plan” to our consolidated financial statements included in this report.
Current report
For the three and nine months ended September 30, 2026, repurchases under the 2026 10b5-1 Plan were as follows:
Reworded paragraphs (2)
Previous wording
On August 8, 2024, our Board of Directors approved and authorized a 10b5-1 stock repurchase program which allows us to repurchase up to $75.00 million of shares of our common stock if our common stock trades below the most recently announced quarter-end NAV per share, subject to certain limitations. On June 13, 2025, we entered into the 2025 10b5-1 Plan with Georgeson for repurchases of our common stock during the period from June 16, 2025 through June 13, 2026. On and effective June 13, 2026, the 2025 10b5-1 Plan expired in accordance with its terms. For the three and six months ended June 30, 2026, we did not repurchase any of our shares under the 2025 10b5-1 Plan.
Current wording
On August 8, 2024, our Board of Directors approved and authorized a 10b5-1 stock repurchase program which allowed us to repurchase up to $75.00 million of shares of our common stock (inclusive of commissions) if our common stock traded below the most recently announced quarter-end NAV per share, subject to certain limitations. On June 13, 2025, we implemented such 10b5-1 stock repurchase program by entering into the 2025 10b5-1 Plan with Georgeson for repurchases of our common stock during the period from June 16, 2025 through June 13, 2026. On and effective June 13, 2026, the 10b5-1 stock repurchase program and the 2025 10b5-1 Plan expired in accordance with its terms. During the three months ended September 30, 2026, the 2025 10b5-1 plan was not in effect. During the three and nine months ended September 30, 2026, we did not repurchase any of our shares under the 2025 10b5-1 Plan.
Previous wording
On May 6, 2026, our Board of Directors approved and authorized a 10b5-1 stock repurchase program, which allows us to enter into the 2026 10b5-1 Plan to repurchase up to $75.00 million of shares of our common stock if the stock trades below the most recently announced quarter-end NAV per share, subject to certain limitations. During the three months ended June 30, 2026, we did not enter into the 2026 10b5-1 Plan and therefore did not repurchase any of our shares thereunder.
Current wording
On May 6, 2026, our Board of Directors approved and authorized a new 10b5-1 stock repurchase program which allows us to repurchase up to $75.00 million of shares of our common stock (inclusive of commissions) if our common stock trades below the most recently announced quarter-end NAV per share, subject to certain limitations. On August 7, 2026, we implemented such new 10b5-1 stock repurchase program by entering into the 2026 10b5-1 Plan with Georgeson for repurchases of our common stock during the period from August 10, 2026 through August 7, 2028 or as further extended by Georgeson and the Company, subject to the approval of the Board.